Sumitomo Pharma America Holdings, Inc., a subsidiary of Sumitomo Pharma Co., Ltd., is headquartered in the United States and operates primarily in North America. Founded in 2015, the company has quickly established itself within the pharmaceutical industry, focusing on innovative treatments in areas such as central nervous system disorders, oncology, and infectious diseases. With a commitment to research and development, Sumitomo Pharma America is known for its unique product offerings, including advanced therapies that address unmet medical needs. The company has achieved significant milestones, including strategic partnerships and a growing portfolio of proprietary medications. As a key player in the pharmaceutical landscape, Sumitomo Pharma America Holdings continues to enhance its market position through a dedication to quality and innovation.
We don't have data for Sumitomo Pharma America Holdings, Inc., but we can show you information about their parent organization instead.
View parent company